查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1976690

助行器市場：依產品類型、技術、最終用戶和通路分類－2026-2032年全球預測

Walking Assist Devices Market by Product Type, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，助行器市值將達到 39.1 億美元，到 2026 年將成長至 41.9 億美元，到 2032 年將達到 64.6 億美元，複合年成長率為 7.42%。

主要市場統計數據
基準年 2025 39.1億美元
預計年份：2026年 41.9億美元
預測年份 2032 64.6億美元
複合年成長率 (%) 7.42%

助行器市場正處於人口結構變化、技術整合和醫療服務模式演變的交匯點。人口老化加劇和行動障礙疾病的增加正在推動對助行器的需求。同時，機器人技術、材料科學和感測器技術的進步正在拓展產品的功能，使其超越基本的機械支撐。因此，從臨床醫生到支付方等相關人員都在重新評估助行器的有效性、安全性和價值。

臨床研究和真實世界數據表明，輔助設備不僅能幫助患者行走，還能促進復原效果，​​並提高患者的獨立生活能力。這促使製造商加大對人體工學設計、自適應控制系統以及與數位健康平台整合的投入。同時，供應鏈趨勢和監管力道也在影響產品設計、測試要求和上市時間。這些因素共同推動行動輔助設備市場從同質化產品轉變為整合硬體、軟體和服務交付的差異化解決方案。

本文強調了產業相關人員亟需調整其創新路線，以適應不斷變化的臨床需求和報銷框架。策略性地優先考慮互通性、臨床醫生培訓和以使用者為中心的設計，將決定哪些產品能夠在臨床實踐中廣泛應用和長期永續性。

機器人技術、感測器智慧、分散式醫療服務以及以結果為導向的商業模式正在改變產品和服務策略。

在技​​術創新、醫療服務模式轉變以及人們對治療效果日益成長的期望的推動下，步行輔助設備領域正經歷著一場變革。機器人和外骨骼技術正從研究機構走向臨床應用和社區，提供主動輔助，與傳統的被動式設備互補。同時，感測器和機器學習技術的進步正在改善自適應控制、跌倒偵測和個人化輔助功能，從而提升安全性和治療價值。

分析 2025 年美國關稅調整對整個助行設備生態系統的採購、成本結構和供應鏈策略的影響。

關稅等政策工具會對助行器製造商、供應商和經銷商的全球供應鏈和商業經濟產生重大影響。在美國，2025 年的關稅政策變化迫使製造商重新評估籌資策略、投入成本管理和跨境物流。特定零件和成品進口關稅的提高推高了到岸成本，促使企業探索替代供應鏈和本地生產方案。

將產品差異、護理環境、分銷網路以及主動技術和被動技術之間的差異聯繫起來的詳細細分分析，將有助於制定有針對性的商業化策略。

細緻的市場區隔分析揭示了產品、終端用戶、分銷和技術等方面的顯著差異，指南策略重點和資源分配。從產品類型來看，市場可分為手杖、拐杖、外骨骼、矯正器具和助行器等類別，並可進一步細分。具體而言，手杖類別包括四點式和單點式手杖的各種變體；拐杖類別包括腋拐和前臂拐；外骨骼類別細分為全身系統和下肢系統；矯正器具類別包括踝矯正器具、髖矯正器具和膝關節矯正器具；助行器類別則區分為可助行器和標準助行滾動器。每種產品類別都面臨不同的臨床預期、監管要求和使用者接受障礙，因此不可能將單一的產品策略普遍應用於所有類型。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢決定了行動輔助解決方案的監管方法、擴散促進因素和商業化路徑。

地理特徵影響行動輔助設備的臨床應用模式、報銷模式、製造地和監管路徑。在美洲，醫療保健系統結合了私人和公共報銷方式，除了傳統的行動輔助設備外，對先進的復健技術也有顯著的需求。該地區的市場參與企業優先考慮的是產生臨床證據、與康復機構合作以及與保險公司合作，以支持保險覆蓋決策和臨床醫生主導的推廣應用。

深入了解影響行動技術領域企業級競爭力的競爭定位、策略夥伴關係關係、智慧財產權的重要性以及服務生態系統。

步行輔助設備領域的競爭格局由差異化的技術平台、臨床檢驗能力和服務生態系統決定。主要企業和新參與企業採取互補的策略：成熟的醫療設備製造商利用分銷網路和臨床關係來推進漸進式創新，而專業的機器人公司和Start-Ups則致力於開發主動式輔助技術和新型控制系統，以拓展治療可能性。這些企業之間的合作十分普遍，策略聯盟、授權協議和共同開發契約等合作方式加速了複雜系統的臨床應用。

為了在行動解決方案領域建立強大的競爭優勢，我們採取了切實可行的策略重點，強調模組化設計、臨床證據、服務擴展和地理多元化。

產業領導者應優先考慮切實可行的策略，以平衡短期韌性和長期差異化。首先，應優先發展模組化產品架構和靈活的零件採購，以降低貿易政策波動帶來的風險，並加速產品線的迭代更新。透過設計支援被動和主動技術的共用平台，企業既能滿足多樣化的臨床需求，又能實現規模經濟。

調查方法結合了專家訪談、二手技術和政策分析以及資料三角驗證，以得出檢驗的見解和可操作的建議。

本調查方法結合了專家定性研究和同行評審文獻、監管文件和公共資料，以確保證據基礎的全面性。主要研究包括對臨床醫生、復健專家、採購經理和醫療設備開發人員進行結構化訪談，以檢驗應用場景、推廣障礙和技術要求。此外，還對產品規格、安全標準和近期臨床試驗進行了技術審查，以評估性能特徵和監管影響。

總之，我們將整合技術、監管和商業性要求，以確定哪些因素將決定哪些行動輔助解決方案能夠實現臨床部署和永續的市場相關性。

行動輔助設備產業正從通用型行動裝置向更複雜的生態系統轉型，該生態系統融合了機械設計、主動輔助技術、數位化服務和以結果為導向的商業模式。這項轉變的驅動力來自人口結構變化、機器人和感測器技術的創新，以及強調分散式居家復健路徑的醫療服務模式的變革。因此，能夠整合臨床證據、適應性產品設計和可擴展服務模式，從而為患者和支付方帶來實際利益的企業，將成為成功的組織。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 助行器市場：依產品類型分類

  • 拐杖
    • 四腳拐杖
    • 單點拐杖
  • 拐杖
    • 腋下拐杖
    • 前臂拐杖
  • 外骨骼
    • 全身
    • 下肢
  • 矯正器具
    • 踝矯正器具
    • 髖關節矯正器具
    • 矯正器具
  • 沃克
    • 滾軸步行者
    • 標準助行器

第9章：助行器市場：依技術分類

  • 積極的
    • 電的
    • 氣動型
  • 被動的
    • 油壓
    • 彈簧型

第10章 助行器市場：依最終用戶分類

  • 居家照護
  • 醫院
  • 復健中心

第11章 助行器市場：依通路分類

  • 醫院和診所
  • 網路藥房
  • 零售藥房

第12章 助行器市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：助行器市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 助行器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國助行器市場

第16章：中國助行器市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bionik Labs Corp.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • Hocoma AG
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • Permobil Inc
  • Pride Mobility Products Corporation
  • ReWalk Robotics Ltd.
  • RxFunction, Inc.
  • Shenzhen Zuowei Technology Co., Ltd.
  • Stryker Corporation
  • Sunrise Medical（US）LLC
  • Synetik ErgoCare
  • Wandercraft SAS
  • Yattil Industry Co., Ltd.
Product Code: MRR-69324464D216

The Walking Assist Devices Market was valued at USD 3.91 billion in 2025 and is projected to grow to USD 4.19 billion in 2026, with a CAGR of 7.42%, reaching USD 6.46 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.91 billion
Estimated Year [2026] USD 4.19 billion
Forecast Year [2032] USD 6.46 billion
CAGR (%) 7.42%

The walking assist devices landscape is at the intersection of demographic shifts, technological convergence, and evolving care delivery models. Aging populations and rising prevalence of mobility-impairing conditions are increasing demand for mobility aids, while simultaneous advances in robotics, materials science, and sensor technology are expanding product capabilities beyond basic mechanical support. As a result, stakeholders from clinicians to payers are recalibrating evaluations of efficacy, safety, and value.

Clinical research and real-world evidence are reinforcing the role of devices that not only enable ambulation but also contribute to rehabilitation outcomes and independence. This has prompted manufacturers to invest in ergonomic design, adaptive control systems, and integration with digital health platforms. Meanwhile, supply chain dynamics and regulatory scrutiny are shaping product design, testing requirements, and commercialization timelines. Taken together, these forces are driving a transition from commoditized mobility aids to differentiated solutions that blend hardware, software, and service delivery.

This introduction frames the urgency for industry players to align innovation pipelines with evolving clinical needs and reimbursement frameworks. Strategic prioritization of interoperability, clinician training, and user-centered design will determine which offerings achieve meaningful clinical adoption and long-term viability.

Transformative changes driven by robotics, sensor intelligence, decentralized care delivery, and outcome-oriented commercial models reshaping product and service strategies

The landscape for walking assist devices is undergoing transformative shifts driven by technological innovation, changing care delivery paradigms, and heightened expectations for outcomes. Robotics and exoskeleton technologies are moving from research labs into clinical and community settings, enabling active assistance that complements traditional passive devices. At the same time, advances in sensors and machine learning are improving adaptive control, fall detection, and personalized assistance, thereby enhancing safety and therapeutic value.

Concurrently, healthcare delivery models are decentralizing: rehabilitation is increasingly delivered in outpatient clinics, home-based programs, and hybrid care pathways that combine in-person therapy with remote monitoring. This decentralization raises demand for devices that are portable, easy to use, and supported by remote clinician interfaces. Regulatory pathways are also evolving to accommodate software-driven features and connected medical devices, which requires developers to prioritize cybersecurity, data privacy, and post-market surveillance.

Moreover, business models are shifting toward bundled services, outcome-based contracting, and device-as-a-service offerings that align vendor incentives with patient outcomes. These transformative shifts require manufacturers and providers to collaborate on clinical validation, training, and reimbursement strategies to ensure sustained adoption and meaningful clinical impact.

Analysis of how 2025 tariff adjustments in the United States are reshaping sourcing, cost structures, and supply chain strategies across the walking assist devices ecosystem

Policy instruments such as tariffs can materially affect the global supply chains and commercial economics of walking assist device manufacturers, suppliers, and distributors. In the United States, tariff policy changes in 2025 have amplified the need for manufacturers to reassess sourcing strategies, input cost management, and cross-border logistics. Increased import duties on certain components and finished goods raise landed costs and incentivize firms to evaluate alternative supply networks or localized production options.

As a consequence, companies are responding with a mix of tactical and strategic measures. Some are diversifying supplier bases across producing regions to mitigate single-source dependency, while others are accelerating nearshoring or onshoring initiatives to reduce exposure to trade policy volatility. Procurement teams are renegotiating contracts to include tariff pass-through clauses or to lock in pricing, while product teams are exploring design adjustments that reduce reliance on tariff-affected components.

These tariff-driven adjustments also influence distribution and channel strategies. Distributors and clinic networks may shift inventory strategies to buffer against cost fluctuations, and manufacturers may revisit margin structures or service bundles to preserve market access. Importantly, regulatory compliance and customs documentation requirements have become more prominent considerations in commercial planning, underscoring the need for integrated cross-functional responses to trade policy shifts.

Deep segmentation analysis linking product variants, care settings, distribution networks, and active versus passive technology distinctions to guide focused commercialization strategies

A nuanced segmentation view reveals distinct product, end-user, distribution, and technology dynamics that inform strategic priorities and resource allocation. When examining product type, the market spans Cane, Crutch, Exoskeleton, Orthosis, and Walker categories, with further differentiation such that the Cane category includes Quad Cane and Single-Point Cane variants, the Crutch category encompasses Axillary Crutch and Forearm Crutch, the Exoskeleton category subdivides into Full Body and Lower Limb systems, the Orthosis category contains Ankle Brace, Hip Brace, and Knee Brace devices, and the Walker category distinguishes Rollator Walker and Standard Walker configurations. Each product family faces different clinical expectations, regulatory considerations, and user adoption barriers, meaning that a single product strategy cannot be universally applied across types.

Across end users, care settings such as Home Care, Hospital, and Rehabilitation Center impose divergent requirements for device durability, training, maintenance, and reimbursement. Home care environments prioritize ease of use, portability, and remote support, whereas hospitals demand robustness, infection control compatibility, and integration with clinical workflows; rehabilitation centers emphasize therapeutic efficacy and device adjustability for progressive regimens. Distribution channel dynamics further shape access and commercialization, with Hospital Clinics, Online Pharmacy, and Retail Pharmacy channels each presenting distinct inventories, fulfillment models, and point-of-sale interactions that influence how devices are presented to clinicians and consumers.

From a technology standpoint, the active versus passive distinction drives performance and regulatory profiles. Active technologies include Motorized and Pneumatic actuation systems that offer powered assistance and require advanced control architectures and safety interlocks, while passive technologies comprising Hydraulic and Spring Based mechanisms offer lower-cost, maintenance-light solutions with simpler regulatory pathways. Strategic positioning should therefore align product development, clinical validation, and go-to-market plans with the specific segmentation attributes that define end-user expectations and reimbursement pathways.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine regulatory approaches, adoption drivers, and commercialization pathways for mobility solutions

Geographic dynamics shape clinical adoption patterns, reimbursement models, manufacturing footprints, and regulatory pathways for walking assist devices. In the Americas, healthcare systems exhibit a mix of private and public reimbursement approaches and demonstrate significant demand for advanced rehabilitation technologies alongside traditional mobility aids. Market participants in this region are prioritizing clinical evidence generation, partnerships with rehabilitation providers, and payer engagement to support coverage decisions and clinician-led adoption.

In Europe, Middle East & Africa, regulatory heterogeneity and varied healthcare infrastructure create both challenges and opportunities. Advanced markets within this region emphasize conformity with rigorous safety and performance standards and favor integrated care models, while emerging markets present opportunities for lower-cost, scalable solutions and distribution partnerships that extend reach into under-resourced settings. Strategic entrants must navigate diverse regulatory regimes, local reimbursement frameworks, and varying clinician training capacities.

Asia-Pacific encompasses a wide spectrum from highly advanced healthcare systems investing in robotics and digital health solutions to rapidly growing markets where demographic trends drive rising demand for accessible mobility aids. Manufacturers and distributors operating in this region are balancing investments in localized manufacturing and regulatory approvals with digital channels and service models that address urban and rural care delivery differentials. Across all regions, cross-border collaborations, technology transfer agreements, and adaptive commercialization models are becoming essential to capture regional opportunities effectively.

Insights into competitive positioning, strategic partnerships, intellectual property importance, and service ecosystems shaping company-level advantages in mobility technology

Competitive dynamics in the walking assist devices sector are defined by differentiated technology platforms, clinical validation capabilities, and service ecosystems. Leading players and new entrants are pursuing complementary strategies: established medical device companies are leveraging distribution networks and clinical relationships to scale incremental innovations, while specialized robotics firms and startups are advancing active-assist technologies and novel control systems that expand therapeutic possibilities. Collaboration between these groups is common, with strategic partnerships, licensing agreements, and co-development arrangements accelerating time-to-clinic for complex systems.

Intellectual property portfolios around actuator design, control algorithms, and sensor fusion are increasingly valuable, and firms investing in meaningful clinical evidence and real-world data collection strengthen their regulatory positioning and payer negotiations. Manufacturing scalability, quality systems, and global regulatory expertise differentiate firms that can supply hospitals and rehabilitation centers at scale from those focused on niche home-care segments. Additionally, after-sales service capabilities, training programs for clinicians, and digital platforms for remote monitoring are emerging as important competitive levers that sustain device utilization and customer satisfaction.

Investors and corporate development teams are watching consolidation and alliance activity closely. Mergers and acquisitions, strategic minority investments, and targeted collaborations are shaping the competitive map, as organizations seek to combine clinical credibility, distribution reach, and cutting-edge technology to deliver comprehensive mobility solutions.

Actionable strategic priorities emphasizing modular design, clinical evidence, service expansion, and geographic diversification to build resilient competitive advantage in mobility solutions

Industry leaders should pursue a set of actionable priorities that balance near-term resilience with long-term differentiation. First, prioritize modular product architectures and adaptable component sourcing to reduce exposure to trade policy disruptions and to accelerate iteration across product lines. By designing shared platforms that accommodate both passive and active technologies, organizations can realize economies of scale while addressing diverse clinical needs.

Second, invest in robust clinical evidence programs and post-market data collection to demonstrate therapeutic value and to support payer discussions. Collaborative studies with rehabilitation centers and hospitals can generate the outcomes data required to underpin reimbursement conversations and clinician adoption. Third, expand service capabilities around training, remote monitoring, and maintenance to increase device utilization and customer retention; integrating digital care pathways will improve patient adherence and clinical oversight.

Fourth, pursue strategic geographic diversification of manufacturing and distribution to mitigate tariff-related risks while preserving market access. Fifth, cultivate partnerships with robotics specialists, materials innovators, and software developers to accelerate the development of next-generation active-assist systems. Finally, align commercial models with stakeholder incentives by experimenting with device-as-a-service offerings and outcome-based agreements that can lower adoption barriers for high-cost technologies.

Methodological approach combining expert interviews, secondary technical and policy analysis, and data triangulation to produce validated insights and actionable recommendations

The research methodology combined primary qualitative engagement with subject-matter experts and secondary synthesis of peer-reviewed literature, regulatory documentation, and public policy materials to ensure a comprehensive evidence base. Primary research included structured interviews with clinicians, rehabilitation specialists, procurement leaders, and device developers to validate use-case scenarios, adoption barriers, and technology requirements. These interviews were complemented by technical reviews of product specifications, safety standards, and recent clinical trials to assess performance characteristics and regulatory implications.

Secondary research encompassed academic journals, standards bodies, device registries, and government policy announcements to construct a contextual framework around demographics, care delivery trends, and trade policy impacts. Data triangulation was applied across sources to corroborate qualitative insights and to identify convergent themes. Analytical approaches included comparative technology assessments, channel mapping, and scenario analysis to evaluate strategic implications of tariffs, supply chain shifts, and regional regulatory variance.

Throughout the process, findings were validated through iterative expert reviews and cross-functional stakeholder consultations to ensure practical relevance and methodological rigor. This approach ensures that recommendations are grounded in clinical realities, regulatory constraints, and operational considerations relevant to manufacturers, providers, and payers.

Conclusion synthesizing technological, regulatory, and commercial imperatives that will determine which mobility solutions achieve clinical adoption and sustained market relevance

The walking assist devices sector is transitioning from commodity-oriented mobility aids to a more sophisticated ecosystem that blends mechanical design, active-assist technologies, digital services, and outcome-focused commercial models. This evolution is driven by demographic demand, innovations in robotics and sensors, and shifts in care delivery that favor decentralized, home-centric rehabilitation pathways. As a result, successful organizations will be those that integrate clinical evidence, adaptive product design, and scalable service models that demonstrate tangible benefits to patients and payers.

Trade policy shifts and supply chain reconfiguration have elevated the importance of sourcing flexibility and regional manufacturing strategies, while distribution channels are evolving to include a stronger role for online and retail pharmacy channels alongside traditional hospital clinic procurement. Competitive advantage will accrue to companies that align technology investments with clinician workflows, invest in training and post-market support, and pursue partnerships that complement in-house capabilities. Ultimately, the most resilient strategies will marry technical innovation with pragmatic commercialization plans that address regulatory compliance, reimbursement dynamics, and end-user usability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Walking Assist Devices Market, by Product Type

  • 8.1. Cane
    • 8.1.1. Quad Cane
    • 8.1.2. Single-Point Cane
  • 8.2. Crutch
    • 8.2.1. Axillary Crutch
    • 8.2.2. Forearm Crutch
  • 8.3. Exoskeleton
    • 8.3.1. Full Body
    • 8.3.2. Lower Limb
  • 8.4. Orthosis
    • 8.4.1. Ankle Brace
    • 8.4.2. Hip Brace
    • 8.4.3. Knee Brace
  • 8.5. Walker
    • 8.5.1. Rollator Walker
    • 8.5.2. Standard Walker

9. Walking Assist Devices Market, by Technology

  • 9.1. Active
    • 9.1.1. Motorized
    • 9.1.2. Pneumatic
  • 9.2. Passive
    • 9.2.1. Hydraulic
    • 9.2.2. Spring Based

10. Walking Assist Devices Market, by End User

  • 10.1. Home Care
  • 10.2. Hospital
  • 10.3. Rehabilitation Center

11. Walking Assist Devices Market, by Distribution Channel

  • 11.1. Hospital Clinics
  • 11.2. Online Pharmacy
  • 11.3. Retail Pharmacy

12. Walking Assist Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Walking Assist Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Walking Assist Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Walking Assist Devices Market

16. China Walking Assist Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bionik Labs Corp.
  • 17.6. Cyberdyne Inc.
  • 17.7. Ekso Bionics Holdings, Inc.
  • 17.8. Hocoma AG
  • 17.9. Myomo, Inc.
  • 17.10. Ottobock SE & Co. KGaA
  • 17.11. Parker-Hannifin Corporation
  • 17.12. Permobil Inc
  • 17.13. Pride Mobility Products Corporation
  • 17.14. ReWalk Robotics Ltd.
  • 17.15. RxFunction, Inc.
  • 17.16. Shenzhen Zuowei Technology Co., Ltd.
  • 17.17. Stryker Corporation
  • 17.18. Sunrise Medical (US) LLC
  • 17.19. Synetik ErgoCare
  • 17.20. Wandercraft SAS
  • 17.21. Yattil Industry Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WALKING ASSIST DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WALKING ASSIST DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY QUAD CANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY QUAD CANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY QUAD CANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SINGLE-POINT CANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SINGLE-POINT CANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SINGLE-POINT CANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY AXILLARY CRUTCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY AXILLARY CRUTCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY AXILLARY CRUTCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FOREARM CRUTCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FOREARM CRUTCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FOREARM CRUTCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FULL BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FULL BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY FULL BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ANKLE BRACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ANKLE BRACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ANKLE BRACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HIP BRACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HIP BRACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HIP BRACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY KNEE BRACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY KNEE BRACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY KNEE BRACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ROLLATOR WALKER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ROLLATOR WALKER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ROLLATOR WALKER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY STANDARD WALKER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY STANDARD WALKER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY STANDARD WALKER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY MOTORIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY MOTORIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY MOTORIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HYDRAULIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HYDRAULIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SPRING BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SPRING BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY SPRING BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REHABILITATION CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REHABILITATION CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REHABILITATION CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY HOSPITAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. GCC WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 211. GCC WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 212. GCC WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 213. GCC WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 217. GCC WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. G7 WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 247. G7 WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 248. G7 WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. G7 WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 253. G7 WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. NATO WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 259. NATO WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 260. NATO WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. NATO WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 264. NATO WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. NATO WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL WALKING ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA WALKING ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY CANE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY CRUTCH, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY EXOSKELETON, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY ORTHOSIS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY WALKER, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA WALKING ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)